A novel series of Wnt antagonists were developed by a scaffold hybridization strategy.
Many compounds exhibited Wnt inhibition at low nM range.
Compound class="boldFont">59 showed excellent chemical, plasma, and liver microsomal stability.
Compound class="boldFont">59 demonstrated good PK profiles with 30% oral bioavailability in rat.